pd 98059 has been researched along with Osteolysis in 2 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Osteolysis: Dissolution of bone that particularly involves the removal or loss of calcium.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Seo, SW | 1 |
Lee, D | 1 |
Minematsu, H | 1 |
Kim, AD | 1 |
Shin, M | 1 |
Cho, SK | 1 |
Kim, DW | 1 |
Yang, J | 1 |
Lee, FY | 1 |
Lentzsch, S | 1 |
Gries, M | 1 |
Janz, M | 1 |
Bargou, R | 1 |
Dörken, B | 1 |
Mapara, MY | 1 |
2 other studies available for pd 98059 and Osteolysis
Article | Year |
---|---|
Targeting extracellular signal-regulated kinase (ERK) signaling has therapeutic implications for inflammatory osteolysis.
Topics: Animals; Cell Line; Drug Delivery Systems; Flavonoids; Inflammation Mediators; Male; MAP Kinase Sign | 2010 |
Macrophage inflammatory protein 1-alpha (MIP-1 alpha ) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells.
Topics: Androstadienes; Cell Division; Cell Survival; Chemokine CCL3; Chemokine CCL4; Cytokines; Enzyme Acti | 2003 |